Our Team

Founder & CEO

Dr. Anooshirvan Shayeganpour is the visionary behind InVitvo Pharmaceuticals, bringing over two decades of expertise in pharmaceutical sciences and drug development. He holds a Ph.D. in Pharmaceutical Sciences from the University of Alberta and previously served as an Associate Professor at Saba University School of Medicine. A prolific researcher with over 21 peer-reviewed publications and book chapters and 1,300+ citations, Dr. Shayeganpour specializes in pharmacokinetics, drug metabolism, and the complex interplay between the gut microbiome and CYP450 enzymes. His expertise in advanced analytical techniques including LC-MS has been instrumental in establishing InVitvo as a leader in high-purity microbial secondary metabolite research.

Co-Founder

Dr. Heidi Rashidi holds a Doctor of Pharmacy degree and brings extensive experience in clinical pharmacy and pharmaceutical research. Her background in drug formulation and quality assurance has been vital to developing InVitvo's high-purity products. She oversees the company's quality control processes and regulatory compliance.